Leverages Keysight’s benchtop instruments to kick-start industrial development of biofuel cells SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS), a leading technology ...
Hosted on MSN
Key genetic characteristics of compatibility when transplanting blood cell-producing stem cells identified
Transplanting hematopoietic stem cells from healthy individuals is one of the possible treatments for blood cancers. In Switzerland, it involves nearly 300 patients per year. However, nearly half of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback